APPLICATION
ANDA202857
TYPE
ANDA
ORIGINAL APPROVAL
2014-09-12
LATEST ACTION
2019-10-03
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
DAPTOMYCINDiscontinued
DAPTOMYCIN 500MG/VIAL · POWDER · INTRAVENOUS
Approval history
2019-10-03Labeling · Supplement 16 · standardAP
2019-10-03Labeling · Supplement 12 · standardAP
2017-07-31Labeling · Supplement 11 · standardAP
2016-12-21Labeling · Supplement 5 · standardAP
2016-12-21Labeling · Supplement 8 · standardAP
2016-12-21Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.